• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体软骨细胞移植治疗膝关节深层软骨缺损

Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.

作者信息

Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L

机构信息

Department of Orthopedic Surgery, University of Göteborg, Sahlgrenska University Hospital, Sweden.

出版信息

N Engl J Med. 1994 Oct 6;331(14):889-95. doi: 10.1056/NEJM199410063311401.

DOI:10.1056/NEJM199410063311401
PMID:8078550
Abstract

BACKGROUND

Full-thickness defects of articular cartilage in the knee have a poor capacity for repair. They may progress to osteoarthritis and require total knee replacement. We performed autologous chondrocyte transplantation in 23 people with deep cartilage defects in the knee.

METHODS

The patients ranged in age from 14 to 48 years and had full-thickness cartilage defects that ranged in size from 1.6 to 6.5 cm2. Healthy chondrocytes obtained from an uninvolved area of the injured knee during arthroscopy were isolated and cultured in the laboratory for 14 to 21 days. The cultured chondrocytes were then injected into the area of the defect. The defect was covered with a sutured periosteal flap taken from the proximal medial tibia. Evaluation included clinical examination according to explicit criteria and arthroscopic examination with a biopsy of the transplantation site.

RESULTS

Patients were followed for 16 to 66 months (mean, 39). Initially, the transplants eliminated knee locking and reduced pain and swelling in all patients. After three months, arthroscopy showed that the transplants were level with the surrounding tissue and spongy when probed, with visible borders. A second arthroscopic examination showed that in many instances the transplants had the same macroscopic appearance as they had earlier but were firmer when probed and similar in appearance to the surrounding cartilage. Two years after transplantation, 14 of the 16 patients with femoral condylar transplants had good-to-excellent results. Two patients required a second operation because of severe central wear in the transplants, with locking and pain. A mean of 36 months after transplantation, the results were excellent or good in two of the seven patients with patellar transplants, fair in three, and poor in two; two patients required a second operation because of severe chondromalacia. Biopsies showed that 11 of the 15 femoral transplants and 1 of the 7 patellar transplants had the appearance of hyaline cartilage.

CONCLUSION

Cultured autologous chondrocytes can be used to repair deep cartilage defects in the femorotibial articular surface of the knee joint.

摘要

背景

膝关节全层关节软骨缺损的修复能力较差。它们可能会发展为骨关节炎,需要进行全膝关节置换。我们对23例膝关节深层软骨缺损患者进行了自体软骨细胞移植。

方法

患者年龄在14至48岁之间,全层软骨缺损面积为1.6至6.5平方厘米。在关节镜检查期间,从受伤膝关节未受累区域获取健康软骨细胞,在实验室中分离并培养14至21天。然后将培养的软骨细胞注入缺损区域。缺损处用取自胫骨近端内侧的带蒂骨膜瓣缝合覆盖。评估包括根据明确标准进行的临床检查以及对移植部位进行活检的关节镜检查。

结果

患者随访16至66个月(平均39个月)。最初,移植治疗消除了所有患者的膝关节交锁症状,并减轻了疼痛和肿胀。三个月后,关节镜检查显示移植组织与周围组织平齐,触诊时有海绵感,边界清晰。第二次关节镜检查显示,在许多情况下,移植组织的宏观外观与早期相同,但触诊时更坚实,外观与周围软骨相似。移植两年后,16例股骨髁移植患者中有14例效果良好至极佳。两名患者因移植组织严重中央磨损出现交锁和疼痛而需要二次手术。移植后平均36个月时,7例髌骨移植患者中有2例效果极佳或良好,3例效果一般,2例效果较差;两名患者因严重软骨软化需要二次手术。活检显示,15例股骨移植中有11例以及7例髌骨移植中有1例呈现透明软骨外观。

结论

培养的自体软骨细胞可用于修复膝关节股骨胫关节面的深层软骨缺损。

相似文献

1
Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.自体软骨细胞移植治疗膝关节深层软骨缺损
N Engl J Med. 1994 Oct 6;331(14):889-95. doi: 10.1056/NEJM199410063311401.
2
[Treatment of deep cartilage defects of the knee with autologous chondrocyte transplantation on a hyaluronic Acid ester scaffolds (Hyalograft C)].[在透明质酸酯支架(Hyalograft C)上进行自体软骨细胞移植治疗膝关节深层软骨缺损]
Acta Chir Orthop Traumatol Cech. 2006 Aug;73(4):251-63.
3
[Treatment of deep chondral defects of the knee using autologous chondrocytes cultured on a support--results after one year].[使用在载体上培养的自体软骨细胞治疗膝关节深层软骨缺损——一年后的结果]
Acta Chir Orthop Traumatol Cech. 2003;70(6):356-62.
4
[Treatment of patellar cartilage defects by solid chondral graft: first experience].[采用实体软骨移植治疗髌骨软骨缺损:首例经验]
Acta Chir Orthop Traumatol Cech. 2004;71(6):339-44.
5
Autologous chondrocyte transplantation for reconstruction of isolated joint defects: the Assaf Harofeh experience.自体软骨细胞移植用于孤立性关节缺损的重建:阿萨夫·哈罗费医院的经验。
Isr Med Assoc J. 2000 Apr;2(4):290-5.
6
The operative treatment of full thickness cartilage defects in the knee joint with autologous chondrocyte transplantation.自体软骨细胞移植治疗膝关节全层软骨缺损的手术治疗
Saudi Med J. 2000 Aug;21(8):715-21.
7
[Autologous chondrocyte transplantation for treatment of cartilage defects of the knee joint. Clinical results].[自体软骨细胞移植治疗膝关节软骨缺损。临床结果]
Zentralbl Chir. 2000;125(6):516-22.
8
[Treatment of deep chondral defects of the knee using autologous chondrocytes cultured on a support--preparation of the cartilage graft].[使用在载体上培养的自体软骨细胞治疗膝关节深层软骨缺损——软骨移植物的制备]
Acta Chir Orthop Traumatol Cech. 2003;70(6):350-5.
9
[Matrix-associated autologous chondrocyte transplantation (MACT). Minimally invasive technique in the knee].[基质相关自体软骨细胞移植(MACT)。膝关节微创技术]
Oper Orthop Traumatol. 2008 Sep;20(3):208-19. doi: 10.1007/s00064-008-1303-1.
10
Autologous chondrocyte implantation improves patellofemoral cartilage treatment outcomes.自体软骨细胞移植可改善髌股关节软骨的治疗效果。
Clin Orthop Relat Res. 2007 Oct;463:187-94.

引用本文的文献

1
Socioeconomic Area Deprivation is Related to Poorer Patient-Reported Outcomes Following Autologous Chondrocyte Implantation (ACI).社会经济区域贫困与自体软骨细胞移植(ACI)后患者报告的较差预后相关。
Cartilage. 2025 Sep 4:19476035251360503. doi: 10.1177/19476035251360503.
2
Effects of a Novel Mammalian-Derived Collagen Matrix on Human Articular Cartilage-Derived Chondrocytes from Osteoarthritis Patients.一种新型哺乳动物源胶原蛋白基质对骨关节炎患者人关节软骨来源软骨细胞的影响。
Int J Mol Sci. 2025 Aug 13;26(16):7826. doi: 10.3390/ijms26167826.
3
Advancements in Chitosan-Based Scaffolds for Chondrogenic Differentiation and Knee Cartilage Regeneration: Current Trends and Future Perspectives.
基于壳聚糖的软骨分化和膝关节软骨再生支架的研究进展:当前趋势与未来展望
Bioengineering (Basel). 2025 Jul 7;12(7):740. doi: 10.3390/bioengineering12070740.
4
The Effects of Hypothermic Storage on Passaged Chondrocyte Viability and Redifferentiation Potential.低温保存对传代软骨细胞活力和再分化潜能的影响。
bioRxiv. 2025 Jun 26:2025.06.20.660742. doi: 10.1101/2025.06.20.660742.
5
The role of synovial mesenchymal stem cell-derived exosomes in cartilage repair: a systematic review.滑膜间充质干细胞衍生外泌体在软骨修复中的作用:一项系统综述
Front Pharmacol. 2025 Jun 25;16:1617874. doi: 10.3389/fphar.2025.1617874. eCollection 2025.
6
Differentiation of Human Induced Pluripotent Stem Cells Toward Implantable Chondroprogenitor Cells.人诱导多能干细胞向可植入软骨祖细胞的分化
Cartilage. 2025 Jul 3:19476035251351713. doi: 10.1177/19476035251351713.
7
Amniotic fluid MSCs for scaffold-free cartilage repair: spheroid fusion and chondrogenic microtissue development.用于无支架软骨修复的羊水间充质干细胞:球体融合与软骨形成微组织发育
Future Sci OA. 2025 Dec;11(1):2476922. doi: 10.1080/20565623.2025.2476922. Epub 2025 Jun 11.
8
Viability of chondrocytes harvested during treatment of hip femoroacetabular impingement.髋关节股骨髋臼撞击症治疗过程中收获的软骨细胞的活力。
Arch Orthop Trauma Surg. 2025 Jun 7;145(1):336. doi: 10.1007/s00402-025-05953-2.
9
Considerations in modern regenerative medicine for osteoarthritis.现代再生医学治疗骨关节炎的考量因素。
EFORT Open Rev. 2025 Jun 2;10(6):336-344. doi: 10.1530/EOR-2025-0050.
10
Current State-Of-Play of the EU Advanced Therapy Medicinal Product (ATMP) Field, With an Emphasis on Belgian Human Cell and Tissue Products.欧盟高级治疗用医药产品(ATMP)领域的现状,重点关注比利时的人类细胞和组织产品。
Wound Repair Regen. 2025 May-Jun;33(3):e70039. doi: 10.1111/wrr.70039.